Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-25.43	21.68	29.07
Graham Fair Price	78.00	2.66	1.49
PEG	-92.86	0.04	-0.52
Price/Book	-8.83	0.95	1.04
Price/Cash Flow	-48.75	-20.80	-13.99
Prices/Earnings	-68.22	7.41	23.32
Price/Sales	-10.13	5.63	6.27
Price/FCF	-48.75	-20.80	-13.99
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.52	0.37	0.36
Operating Margin	149.00	0.22	0.09
ROA	195.77	0.02	< 0.005
ROE	0.01	0.03	186.92
ROIC	< 0.005	0.02	186.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	0.03	274.48
Dividends QOQ	-0.66	-0.78	-17.76
EBIT QOQ	-0.23	1.65	624.24
EPS QOQ	-0.45	2.01	345.00
FCF QOQ	-4.34	0.36	-91.77
Revenue QOQ	-0.07	0.06	-8.07
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	41.40	59.06	42.64
Days Sales Outstanding (DSO)	49.80	57.21	14.89
Inventory Turnover	2.17	1.52	-29.89
Debt/Capitalization	0.27	0.28	5.24
Quick Ratio	1.36	1.66	21.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.98	3.14	5.08
Cash	1.53	1.52	-0.83
Capex	-0.21	-0.09	59.05
Free Cash Flow	-0.22	-0.14	35.59
Revenue	0.49	0.53	6.60
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.62	1.99	23.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.68	-2.22	52.45
Naive Interpretation	Member

06 - Financial Health · Weak

Rating